Literature DB >> 8575620

The distribution of collapsin-1 mRNA in the developing chick nervous system.

I Shepherd1, Y Luo, J A Raper, S Chang.   

Abstract

Collapsin-1 is a secreted glycoprotein that inhibits the extension of specific growth cones in vitro. It has been hypothesized to serve as a repulsive guidance cue for extending growth cones in vivo. Here we report the distribution of collapsin-1 message as demonstrated by in situ hybridization using digoxigenin-labeled RNA probes in wholemounts and tissue sections. In the early chick brain collapsin-1 is expressed in specific regions of the retina, the olfactory bulb, and the diencephalon. In the hindbrain collapsin-1 is first expressed in rhombomere 5 and later in bilaterally symmetric rostrocaudal stripes. Collapsin-1 is expressed in high levels in the ventral horn of the spinal cord and in ventricular stripes that extend rostrally to the hindbrain. In the periphery, collapsin-1 is expressed in the dermamyotome and in ectoderm and epidermis. Based on collapsin's expression patterns we tested axons extending from explants of ventral spinal cord and olfactory bulb for sensitivity to collapsin and show that the former are sensitive to collapsin whereas the latter are not. The distribution of collapsin mRNA is consistent with it playing a role in the organization of sensory axonal projections within the spinal cord and skin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8575620     DOI: 10.1006/dbio.1996.0016

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  24 in total

1.  Embryonic expression and extracellular secretion of Xenopus slit.

Authors:  J H Chen; W Wu; H S Li; T Fagaly; L Zhou; J Y Wu; Y Rao
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

2.  The "waiting period" of sensory and motor axons in early chick hindlimb: its role in axon pathfinding and neuronal maturation.

Authors:  G Wang; S A Scott
Journal:  J Neurosci       Date:  2000-07-15       Impact factor: 6.167

3.  Adenoviral vector-mediated expression of B-50/GAP-43 induces alterations in the membrane organization of olfactory axon terminals in vivo.

Authors:  A J Holtmaat; W T Hermens; M A Sonnemans; R J Giger; F W Van Leeuwen; M G Kaplitt; A B Oestreicher; W H Gispen; J Verhaagen
Journal:  J Neurosci       Date:  1997-09-01       Impact factor: 6.167

4.  Sema3D, Sema3F, and Sema5A are expressed in overlapping and distinct patterns in chick embryonic heart.

Authors:  Zhe Jin; Mary D Chau; Zheng-Zheng Bao
Journal:  Dev Dyn       Date:  2006-01       Impact factor: 3.780

5.  Selective innervation of fast and slow muscle regions during early chick neuromuscular development.

Authors:  V F Rafuse; L D Milner; L T Landmesser
Journal:  J Neurosci       Date:  1996-11-01       Impact factor: 6.167

6.  The chemorepulsive activity of secreted semaphorins is regulated by furin-dependent proteolytic processing.

Authors:  R H Adams; M Lohrum; A Klostermann; H Betz; A W Püschel
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

7.  Sema3D and Sema7A have distinct expression patterns in chick embryonic development.

Authors:  Zheng-Zheng Bao; Zhe Jin
Journal:  Dev Dyn       Date:  2006-08       Impact factor: 3.780

8.  Evidence for a role of the chemorepellent semaphorin III and its receptor neuropilin-1 in the regeneration of primary olfactory axons.

Authors:  R J Pasterkamp; F De Winter; A J Holtmaat; J Verhaagen
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

9.  Sema3A maintains corneal avascularity during development by inhibiting Vegf induced angioblast migration.

Authors:  Chelsey C McKenna; Ana F Ojeda; James Spurlin; Sam Kwiatkowski; Peter Y Lwigale
Journal:  Dev Biol       Date:  2014-05-06       Impact factor: 3.582

10.  FARP1 promotes the dendritic growth of spinal motor neuron subtypes through transmembrane Semaphorin6A and PlexinA4 signaling.

Authors:  BinQuan Zhuang; YouRong Sophie Su; Shanthini Sockanathan
Journal:  Neuron       Date:  2009-02-12       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.